Home » Topics » BioWorld

BioWorld
RSS

CELLCOR IPO RAISES $22 MILLION

March 16, 1992

NIH PATENT CLAIMS MANY VARIATIONS

March 13, 1992

ANOTHER ALZHEIMER'S MODEL RETRACTED

March 13, 1992

FDA PANEL VOTES FOR CHIRON BLOOD TEST

March 13, 1992

SYNTHECELL TO ACQUIRE VEGA BIOTECH

March 13, 1992

METRA BOOSTS SECOND-ROUND STAKE

March 13, 1992

THERATECH FILES FOR IPO

March 12, 1992

ANERGEN COMPOUND QUELLS MUSCLE DISORDER IN RATS

March 12, 1992

ISIS DEAL TO DELIVER ANTISENSE WITH VICAL'S LIPIDS

March 12, 1992

ECOGEN ENTERS NEMATODE BUSINESS

March 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...